Carlos S Moreno

11PUBLICATIONS
40CO-AUTHORS
Predictive and prognostic markersMolecular targetsMedical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Dec 09, 2023
Integrated Genomic Analysis of Primary Prostate Tumor Foci and Corresponding Lymph Node Metastases Identifies Mutations and Pathways Associated with Metastasis.

Carlos S Moreno, Cynthia L Winham, Mehrdad Alemozaffar

|Jun 13, 2022
High throughput, label-free isolation of circulating tumor cell clusters in meshed microwells.

Mert Boya, Tevhide Ozkaya-Ahmadov, Brandi E Swain

|Feb 08, 2022
The Movember Global Action Plan 1 (GAP1): Unique Prostate Cancer Tissue Microarray Resource.

Véronique Ouellet, Andrew Erickson, Kathy Wiley

|May 28, 2020
EZH2 has a non-catalytic and PRC2-independent role in stabilizing DDB2 to promote nucleotide excision repair.

Allyson E Koyen, Matthew Z Madden, Dongkyoo Park

|May 02, 2020
Genomic copy number variation correlates with survival outcomes in WHO grade IV glioma.

Zachary S Buchwald, Sibo Tian, Michael Rossi

|Feb 22, 2020
Combined HER3-EGFR score in triple-negative breast cancer provides prognostic and predictive significance superior to individual biomarkers.

Angela Ogden, Shristi Bhattarai, Bikram Sahoo

Pageof 2

Frequent Collaborators

2 joint publications

Veronique Ouellet

2 joint publications

David S Yu

2 joint publications

Nicholas T Seyfried

2 joint publications

Zachary D Nagel